-
Signature
-
/s/ John B. Moriarty, Jr., J.D., Attorney-in-Fact
-
Stock symbol
-
RNA
-
Transactions as of
-
Aug 6, 2025
-
Transactions value $
-
-$3,919,170
-
Form type
-
4
-
Date filed
-
8/8/2025, 05:42 PM
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| WILSON TROY EDWARD |
Director |
C/O AVIDITY BIOSCIENCES, INC., 10578 SCIENCE CENTER DRIVE, SUITE 125, SAN DIEGO |
/s/ John B. Moriarty, Jr., J.D., Attorney-in-Fact |
2025-08-08 |
0001589597 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
RNA |
Common Stock |
Options Exercise |
$265K |
+22K |
+31.69% |
$12.03 |
91.4K |
Aug 6, 2025 |
Direct |
F1 |
| transaction |
RNA |
Common Stock |
Sale |
-$990K |
-22K |
-24.06% |
$45.00 |
69.4K |
Aug 6, 2025 |
Direct |
F1 |
| transaction |
RNA |
Common Stock |
Options Exercise |
$93.6K |
+7.5K |
+10.8% |
$12.48 |
76.9K |
Aug 6, 2025 |
Direct |
F1 |
| transaction |
RNA |
Common Stock |
Sale |
-$338K |
-7.5K |
-9.75% |
$45.00 |
69.4K |
Aug 6, 2025 |
Direct |
F1 |
| transaction |
RNA |
Common Stock |
Sale |
-$675K |
-15K |
-5% |
$45.00 |
285K |
Aug 6, 2025 |
By irrevocable trust 1 |
F1 |
| transaction |
RNA |
Common Stock |
Sale |
-$675K |
-15K |
-5% |
$45.00 |
285K |
Aug 6, 2025 |
By irrevocable trust 2 |
F1 |
| transaction |
RNA |
Common Stock |
Sale |
-$800K |
-17.8K |
-50% |
$45.00 |
17.8K |
Aug 6, 2025 |
By irrevocable trust 3 |
F1 |
| transaction |
RNA |
Common Stock |
Sale |
-$800K |
-17.8K |
-50% |
$45.00 |
17.8K |
Aug 6, 2025 |
By irrevocable trust 4 |
F1 |
| holding |
RNA |
Common Stock |
|
|
|
|
|
11.9K |
Aug 6, 2025 |
By irrevocable trust 5 |
|
| holding |
RNA |
Common Stock |
|
|
|
|
|
11.9K |
Aug 6, 2025 |
By irrevocable trust 6 |
|
| holding |
RNA |
Common Stock |
|
|
|
|
|
13.7K |
Aug 6, 2025 |
By family trust |
|
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
RNA |
Stock Option (Right to Buy) |
Options Exercise |
$0 |
-22K |
-100% |
$0.00 |
0 |
Aug 6, 2025 |
Common Stock |
22K |
$12.03 |
Direct |
F1, F2 |
| transaction |
RNA |
Stock Option (Right to Buy) |
Options Exercise |
$0 |
-7.5K |
-34.09% |
$0.00 |
14.5K |
Aug 6, 2025 |
Common Stock |
7.5K |
$12.48 |
Direct |
F1, F2 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: